MK
Matthew Keller HC Wainwright & Co Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
14
Avg Return
Past Year
Past Year
19%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
92.9%
Neutral
7.1%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Reiterated
| $14 |
1,076%
upside
| 2 | -8.3% |
0
%
| 10 Feb ‘26 2 months ago |
|
|
|
Buy
Maintained
| $24 |
1,372%
upside
| 2 | +129% |
0
%
| 27 Jan ‘26 2 months ago |
|
|
|
Buy
Reiterated
| $6 |
305%
upside
| 2 | -22% |
0
%
| 30 Dec ‘25 3 months ago |
|
|
|
Buy
Maintained
| $11 |
372%
upside
| 2 | +10% |
0
%
| 17 Dec ‘25 4 months ago |
|
|
|
Neutral
Downgraded
| – | – | 1 | – |
–
| 30 Oct ‘25 5 months ago |
|
|
|
Buy
Reiterated
| $31 |
1,466%
upside
| 2 | +5.7% |
0
%
| 30 Sep ‘25 6 months ago |
|
|
|
Buy
Reiterated
| $43 |
502%
upside
| 2 | +14% |
0
%
| 24 Sep ‘25 7 months ago |
|
|
|
Buy
Initiated
| $18 |
142%
upside
| 1 | -7.3% |
0
%
| 26 Aug ‘25 8 months ago |
|